
Targeted Capacity Expansion: Special Projects
Short Title:
TCE-Special Projects
Initial Announcement
Back to the Grants Dashboard
Notice of Funding Opportunity (NOFO)
NOFO Number: TI-25-002
Posted on Grants.gov: Friday, June 27, 2025
Application Due Date: Tuesday, July 15, 2025
Catalog of Federal Domestic Assistance (CFDA) Number: 93.243
Intergovernmental Review (E.O. 12372): Applicants must comply with E.O. 12372 if their state(s) participates. Review process recommendations from the State Single Point of Contact (SPOC) are due no later than 60 days after application deadline.
Public Health System Impact Statement (PHSIS) / Single State Agency Coordination: Applicants must send the PHSIS to appropriate State and local health agencies by application deadline. Comments from Single State Agency are due no later than 60 days after application deadline.
Description
The purpose of this program is to implement targeted strategies to provide treatment and related services for substance use disorder (SUD) and/or co-occurring disorder (COD) to communities disproportionately impacted by SUD/COD. Recipients will use public health data to identify the SUD/COD treatment needs in the community that this program will support with evidence-based and population-appropriate treatment and related services.
Eligibility
Eligible applicants are domestic, public, and private nonprofit entities.
Award Information
Funding Mechanism: Grant
Anticipated Total Available Funding: Up to $7,125,000
Anticipated Number of Awards: Up to 19 awards
Anticipated Award Amount: Up to $375,000 per year per award
Length of Project: Up to 3 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $375,000 in total costs (direct and indirect) in any year of the proposed project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.

Distribution channels: Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release